While synovial pJAK3 predominantly localized to CD3+ T cells, vimentin-expressing synovial fibroblasts were also JAK3 positive (46), supporting the role of JAK3 inihbition in synovial fibroblasts in RA. Here, JAK3 is linked to rheumatoid arthritis.